HCW Biologics Inc.: stockholders equity

What this measure means

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Exact concept: us-gaap:StockholdersEquity. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2019-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• HCW Biologics Inc.: total assets
• HCW Biologics Inc.: total liabilities
• HCW Biologics Inc.: cash and cash equivalents
• HCW Biologics Inc.: net income or loss
• HCW Biologics Inc.: operating cash flow
• HCW Biologics Inc.: capital expenditure payments
• HCW Biologics Inc.: financing cash flow
• HCW Biologics Inc.: investing cash flow
• HCW Biologics Inc.: retained earnings or deficit
• HCW Biologics Inc.: basic weighted-average shares
• HCW Biologics Inc.: diluted weighted-average shares
• HCW Biologics Inc.: basic earnings per share
• HCW Biologics Inc.: diluted earnings per share
• HCW Biologics Inc.: net property, plant and equipment
• HCW Biologics Inc.: share-based compensation expense
• HCW Biologics Inc.: operating income or loss
• HCW Biologics Inc.: current assets
• HCW Biologics Inc.: interest expense
• HCW Biologics Inc.: current liabilities
• HCW Biologics Inc.: current accounts payable
• HCW Biologics Inc.: operating expenses
• HCW Biologics Inc.: gross profit
• HCW Biologics Inc.: cost of revenue
• HCW Biologics Inc.: research and development expense

Inspect the source

Entity

HCW Biologics Inc. / CIK 0001828673

Captured

2026-09-21T17:29:55.000Z

SEC response SHA-256

ec2f89184d2effc79bd61262508df1bb4955251bd9c779b166cb9345b80a8cfa

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001828673.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))